Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2003
02/20/2003CA2453485A1 Pramipexole for the treatment of adhd
02/20/2003CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003CA2453219A1 Therapeutically useful tetracyclic ligands
02/20/2003CA2452803A1 Tricyclic imidazopyridines
02/20/2003CA2451914A1 Combination therapy for the treatment of neurological disorders
02/20/2003CA2451691A1 Use of r-nsaid compounds for anti-hiv treatment
02/20/2003CA2450777A1 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
02/20/2003CA2419389A1 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
02/19/2003EP1284423A2 Adrenic acid (delta 7,10,13,16 docosatetraenoic acid ) receptor and uses thereof
02/19/2003EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
02/19/2003EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them
02/19/2003EP1284268A1 Thiazolidinedione derivative and its use as antidiabetic
02/19/2003EP1284267A1 Triazole compounds having amide linkage
02/19/2003EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
02/19/2003EP1284265A1 Benzothiophene derivatives and medicinal use thereof
02/19/2003EP1284263A1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
02/19/2003EP1284260A1 Tyrosine phosphatase inhibitors
02/19/2003EP1284259A1 5,6- i TRANS /i -2-ALKYLVITAMIN D DERIVATIVES
02/19/2003EP1284257A2 Difluoromethylene aromatic ethers and their use as inhibitors of the glycine type-1 transporter
02/19/2003EP1284151A1 Topical treatment of pain and to promote healing including capsaicin as an analgesic
02/19/2003EP1284141A2 Pharmaceutical combinations comprising neuronal nitric oxide synthase inhibitors for the treatment of neurodegenerative diseases
02/19/2003EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
02/19/2003EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver
02/19/2003EP1284137A1 Nonoral preparation having three-layer structure
02/19/2003EP1284134A2 External skin preparations for suppressing sebum secretion
02/19/2003EP1284133A1 Mixtures of active agents
02/19/2003EP1283905A2 Diagnosis of diseases associated with the cell cycle
02/19/2003EP1283889A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
02/19/2003EP1283885A2 Compositions and methods for the therapy and diagnosis of breast cancer
02/19/2003EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
02/19/2003EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
02/19/2003EP1283880A1 Antiviral antisense therapy
02/19/2003EP1283848A2 Protein complexes and assays for screening anti-cancer agents
02/19/2003EP1283845A1 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
02/19/2003EP1283839A1 Adenosine a2a receptor antagonists
02/19/2003EP1283838A1 Piperazine and piperidine compounds
02/19/2003EP1283837A1 New thiochromane derivatives and their use as thrombin inhibitors
02/19/2003EP1283836A2 Neuroprotective and anti-proliferative compounds
02/19/2003EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
02/19/2003EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/19/2003EP1283830A1 Para-amine substituted phenylamide glucokinase activators
02/19/2003EP1283828A1 Novel polymorph v of torasemide
02/19/2003EP1283827A2 Caspase inhibitors and uses thereof
02/19/2003EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
02/19/2003EP1283823A1 Novel mmp-2/mmp-9 inhibitors
02/19/2003EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
02/19/2003EP1283726A2 Dendritic cells loaded with toxic substances
02/19/2003EP1283725A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
02/19/2003EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
02/19/2003EP1283722A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
02/19/2003EP1283713A2 Combined cartilage and plant extract compositions
02/19/2003EP1283712A1 Combination chemotherapy
02/19/2003EP1283711A1 Peptide deformylase inhibitors
02/19/2003EP1283710A1 Use of a celecoxib composition for fast pain relief
02/19/2003EP1283709A1 Peptide deformylase inhibitors
02/19/2003EP1283708A2 Use of biguanide derivatives for making a medicine having a wound healing effect
02/19/2003EP1283707A1 Polymerizable compositions and methods of use
02/19/2003EP1283706A1 Dosage of transdermal delivery systems
02/19/2003EP1283704A2 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
02/19/2003EP1283700A2 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds
02/19/2003EP1283699A2 Preparation of injectable suspensions having improved injectability
02/19/2003EP1283682A2 Tryptophan source from plants and uses therefor
02/19/2003EP1283675A1 Methods of modulating the activity of mura
02/19/2003EP1283672A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
02/19/2003EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
02/19/2003EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
02/19/2003EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
02/19/2003EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases
02/19/2003EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists
02/19/2003EP1115729B1 Phosphonic acid derivatives as inhibitors of ptp-1b
02/19/2003EP1087777B1 Therapeutic dinucleotide and derivatives
02/19/2003EP1066040B1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
02/19/2003EP1056749B1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS
02/19/2003EP1039888B1 Method of increasing the production and improving the quality of semen
02/19/2003EP1033131B1 Composition in the form of a drink having a delayed alcohol aversion effect
02/19/2003EP1027345B1 Synthetic methods for polyphenols
02/19/2003EP1001788B1 Boron carbohydrate complexes and uses thereof
02/19/2003EP0994863B1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
02/19/2003EP0988302B1 Benzonaphthyridines
02/19/2003EP0959892B1 Use of pvp or povidone for reducing bowel distension
02/19/2003EP0931083B1 Process for producing ecteinascidin compounds
02/19/2003EP0930870B1 Preparation protecting skin from mechanical irritation
02/19/2003EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
02/19/2003EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
02/19/2003EP0917530B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
02/19/2003EP0872246B1 Drug for relieving pain and promoting the removal of calculi in urolithiasis
02/19/2003EP0868175B1 Nitric oxide (no) synthase inhibitor to prevent type ii diabetes
02/19/2003EP0863752B1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
02/19/2003EP0817786B1 Substituted tetronic acids useful for treating hiv and other retroviruses
02/19/2003EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
02/19/2003EP0795024B1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation
02/19/2003EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
02/19/2003EP0774969B1 Hiv protease inhibitor combination
02/19/2003EP0750618B1 Oxazolidinone derivatives and pharmaceutical compositions containing them
02/19/2003EP0732926B1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors
02/19/2003EP0729363B1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors
02/19/2003EP0690867B1 Taxanes having furyl or thienyl substituted side-chain
1 ... 5559 5560 5561 5562 5563 5564 5565 5566 5567 5568 5569 5570 5571 5572 5573 5574 5575 5576 5577 5578 5579 ... 7860